5 Most Promising Gene Editing Stocks According to Hedge Funds

Page 5 of 5

1. NVIDIA Corporation (NASDAQ:NVDA)

Number of Hedge Fund Investors In Q3 2023: 180

NVIDIA Corporation (NASDAQ:NVDA) is a semiconductor company that designs and sells graphics processing units (GPUs). It is also a key player in the gene editing industry through its Clara computing platform that leverages A.I. to accelerate genomics.

As Q3 2023 ended, 180 out of the 910 hedge funds part of Insider Monkey’s database had bought and owned NVIDIA Corporation (NASDAQ:NVDA)’s shares. Rajiv Jain’s GQG Partners was the largest shareholder through its $6.1 billion investment.

Follow Nvidia Corp (NASDAQ:NVDA)

Disclosure: None. You can also take a look at 12 Most Profitable Cheap Stocks To Buy and Wall Street Analysts Just Trimmed Price Targets for These 10 Stocks.

Follow Insider Monkey on Twitter

Page 5 of 5